Making CRISPR-Cas9 gene editing safer with artificial intelligence

CRISPR gene editing was launched into the spotlight this week when Chinese scientist, He Jiankui, claimed to have made the world’s first genome-edited babies using the technology. The resulting ethical debate about manipulating the human germline was important, to be sure, but it overshadowed a more immediate concern: Before CRISPR research can be safely translated into therapies, scientists will need better methods for avoiding potential damaging off-target effects of the technology.